Researchers from the Harvard AIDS Initiative and the Botswana Harvard AIDS Institute made significant contributions to the 21st International AIDS Conference (AIDS 2016), held July 18-22, in Durban, South Africa. Here is a list of their presentations:
Sessions
Taking TB from Testing to Treatment
Co-chair: Tendani Gaolathe
Going Viral for Viral Load Implementation
Monitoring of HIV-1 RNA with point-of-care cepheid Xpert HIV-1 viral load in rural African communities is feasible and reliable in the era of broad scale up of ART
Sikhulile Moyo
Measuring Progress Towards 90-90-90
Cross-sectional estimates of HIV incidence remain high in rural communities in Botswana in the era of successful scale up of ART
Sikhulile Moyo
Past, Present and Future of HIV/AIDS in Resource-Limited Settings
Implementation science: The Test & Treat approach in resource-limited settings
Tendani Gaolathe
Abstracts
Simplifying data management for household-level combination prevention research in resource-limited settings with reusable open-source software: developing and deploying an electronic research data system for the Botswana Combination Prevention Project
Presenter: Erik van Widenfelt
Stand-alone health data systems in remote ART clinics in Botswana can be centralized over inexpensive low-bandwidth connections: the example of the Botswana Combination Prevention Project Research Data Network
Presenter: Erik van Widenfelt
Low rates of cholesterol screening despite cardiovascular risk in protease inhibitor-treated HIV patients in Botswana
Presenter: Mosepele Mosepele
Demonstrating regulatory compliance of a novel electronic data management system in large scale community-based HIV prevention trial in Botswana
Presenter: Tumalano Sekoto
Estimation of HIV incidence using retrospectively-collected HIV testing history in Botswana
Presenter: Nadia N. Abuelezam
Cross-sectional estimates of HIV incidence remain high in rural communities in Botswana in the era of successful scale up of ART
Presenter: Sikhulile Moyo
Comparison of neurodevelopmental outcomes between HIV-exposed uninfected infants vs. HIV-unexposed infants
Presenter: Jean Leidner
Monitoring of HIV-1 RNA with point-of-care cepheid Xpert HIV-1 viral load in rural African communities is feasible and reliable in the era of broad scale up of ART
Presenter: Sikhulile Moyo
High proportion of deaths attributable to HIV among post-partum women in Botswana despite widespread uptake of ART
Presenter: Rebecca Zash
Community engagement in research unearths community health needs
Presenter: Ernest Mosimanegape Moseki
Response to Truvada based cART in HIV/HBV co-infected patients in Botswana
Presenter: Motswedi Anderson
Predominance of hepatitis B virus genotype D in HIV-1 subtype C co-infected patients with occult hepatitis B in Botswana
Presenter: Simani Gaseitsiwe
Increased risk of morbidity/mortality among formula fed HIV-exposed uninfected infants in socioeconomically challenged households in Botswana: findings from the Mpepu study
Presenter: Kathleen Powis
The endotoxin-lipoprotein hypothesis, obesity and HIV
Presenter: Sabrina Martinez
Randomized trial of stopping or continuing ART among post-partum women with pre-ART CD4 > 400 cells/mm (PROMISE 1077HS)
Presenter: Judith Currier
Low acceptance of early antiretroviral therapy (ART) among post-partum women enrolled in IMPAACT PROMISE studies across the globe
Presenter: Lynda Stranix-Chibanda
Title image: The Botswana Combination Prevention Project leadership team meets in the Botswana Harvard AIDS Institute conference room. Photo by Dominic Chavez